Aspen Neuroscience

Aspen Neuroscience is a biotech company in San Diego, United States, founded in 2018. It has raised $347.0M across 5 rounds, most recently a $115.0M Series C in November 2025.

Personalized medicine begins with you

Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$347.0M
Last Round
$115.0M Series CNov 2025
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 17 investors for this company. The full record is or through the API.

About

Aspen Neuroscience is a clinical-stage biotech developing ANPD001, the world's first autologous iPSC-derived neuron replacement therapy for Parkinson's disease. Using a patient's own skin cells reprogrammed into dopamine-producing neurons, the treatment eliminates immunosuppression requirements and is currently in Phase 1/2a clinical trials.

Summary

It lists 51–200 employees. It has raised $347.0M in total across 5 rounds, most recently a $115.0M Series C round in Nov 2025. Investors include ARCH Venture Partners, OrbiMed and Revelation Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CNov 2025
$115.0M

Sign up to see all 5 events

Funding: Seed through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aspen Neuroscience on Indexed.vc
<a href="https://indexed.vc/companies/aspen-neuroscience"><img src="https://indexed.vc/api/badge/company/aspen-neuroscience" alt="Aspen Neuroscience on Indexed.vc" width="260" height="76" /></a>